Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6114821 | Current Opinion in Immunology | 2016 | 7 Pages |
Abstract
Activation of CD4+ T cells through interactions with peptides bound to Major Histocompatibility Complex Class II (MHC-II) molecules is a crucial step in clearance of most pathogens. Consequently, many viruses have evolved ways of blocking this aspect of adaptive immunity, from specific targeting of processing and presentation components to modulation of signaling pathways that regulate peptide presentation in addition to many other host defense mechanisms. Such cases of interference are far less common compared to what has been elucidated in MHC-I processing and presentation. This may be attributable in part to the complexity of MHC-II antigen processing, the scope of which is only now coming to light.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Katherine S Forsyth, Laurence C Eisenlohr,